İçeriğe geç
akaturk Akademik ölçüm

OpenAlex konusu

Neurogenetic and Muscular Disorders Research

Bu sayfa OpenAlex konu etiketine göre çalışmaları ve o konuda görünen akademisyenleri listeler. YÖKSİS temel alan / yan dal değildir.

OpenAlex 1.712 eser 34 yazar konusu

Çalışmalar

1.712 eser

  1. Pediatric Spinal Muscular Atrophy Patients Treated With Nusinersen: Experience From a Tertiary Referral Center in Turkey 2026

    Özet henüz yok.

  2. Correction: From policy to practice: premarital spinal muscular atrophy screening as a public health initiative in northern Türkiye 2026

    [This corrects the article DOI: 10.3389/fpubh.2025.1714795.].

  3. A novel deep intronic EIF2AK3 variant disrupts splicing and causes Wolcott–Rallison syndrome 2026

    AIM: Deep intronic variants can disrupt splicing and cause monogenic disease but are missed by routine genetic testing. This study assessed the contribution of deep intronic variants to Wolcott-Rallison syndrome (WRS), a recessive disorder characterized by early-onset diabetes and progressive multisystem disease cause…

  4. Orthopaedic Complications in Infancy 2026

    Orthopaedic complications encountered during infancy include a broad spectrum of positional deformities, congenitalanomalies, developmental disorders and neuromuscular conditions affecting the musculoskeletal system. Positional deformitiessuch as intoeing, metatarsus adductus, talipes equinovarus, calcaneovalgus, genu…

  5. Orthopaedic Complications in Infancy 2026

    Orthopaedic complications encountered during infancy include a broad spectrum of positional deformities, congenitalanomalies, developmental disorders and neuromuscular conditions affecting the musculoskeletal system. Positional deformitiessuch as intoeing, metatarsus adductus, talipes equinovarus, calcaneovalgus, genu…

  6. Presymptomatic risdiplam treatment in an infant with homozygous SMN1 deletion and two SMN2 copies: age-appropriate motor development at 6 months 2026

    Abstract Background Spinal muscular atrophy (SMA) is a progressive neuromuscular disorder caused by biallelic SMN1 deletion or mutation, leading to degeneration of anterior horn motor neurons. Newborn screening enables presymptomatic diagnosis, and timely initiation of disease-modifying therapy is associated with impr…

  7. Comparison of Nusinersen Monotherapy Versus Combination Therapy With Nusinersen and Onasemnogene Abeparvovec in Spinal Muscular Atrophy Type 1 Patients With Two SMN2 Copies: A Multicenter Study From Türkiye 2026

    INTRODUCTION/AIMS: Data comparing nusinersen monotherapy with combination therapy using nusinersen and onasemnogene abeparvovec (OA) in spinal muscular atrophy (SMA) type 1 patients are limited. This study aimed to compare the clinical outcomes of nusinersen monotherapy versus combination therapy (nusinersen and OA) i…

  8. Çocuklarda Otozomal Dominant Polikistik Böbrek Hastalığı 2026

    Özet henüz yok.

  9. Tay-Sachs disease models: From cellular and animal models to treatment perspectives 2026

    Özet henüz yok.

  10. Extremity Pain in a Patient with Diffuse Muscle Weakness: A Clinical Picture Orchestrated by Two Uncommon Mutations 2026

    ABS TRACT This case report presents a 36-year-old female presenting with burning lower extremity pain, proximal muscle weakness, and imbalance.Her clinical examination revealed diffuse proximal weakness, with mild distal involvement, and left ptosis.Routine laboratory and imaging results were unremarkable, and electro…

  11. Quantitative Ultrasonographic Assessment of Muscle Structure and Correlations With Motor Function Scales in Nusinersen-Treated Children With Spinal Muscular Atrophy 2026

    Özet henüz yok.

  12. The Dilemma of Providing Advanced Hemophilia Treatments in Developing Countries – For Whom, by Whom and Where? 2026

    Hemophilia, a congenital deficiency of factor VIII (hemophilia A) or factor IX (hemophilia B), leads to recurrent bleeding episodes that may cause progressive joint damage and long-term disability. Traditional management relies on intravenous factor replacement therapy; however, limited half-life, immunogenicity, veno…

Akademisyenler

34 akademisyen